Search

Quest Diagnostics Inc

Fermé

SecteurSoins de santé

235.5 0.06

Résumé

Variation du prix de l'action

24h

Actuel

Min

232

Max

236.07

Chiffres clés

By Trading Economics

Revenu

70M

334M

Ventes

148M

3B

P/E

Moyenne du Secteur

25.201

56.597

BPA

3.12

Rendement du dividende

1.39

Marge bénéficiaire

10.976

Employés

46,000

EBITDA

47M

481M

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+7.86% upside

Dividendes

By Acuity

Rendement du dividende

Moyenne du Secteur

1.39%

2.18%

Prochains Résultats

20 oct. 2026

Date du Prochain Dividende

21 oct. 2026

Date du Prochain Détachement de Dividende

6 oct. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

3.2B

26B

Ouverture précédente

235.44

Clôture précédente

235.5

Sentiment de l'Actualité

By Acuity

15%

85%

12 / 339 Classement par Healthcare

Quest Diagnostics Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

9 sept. 2026, 21:01 UTC

News

Quest Diagnostics shares are lower after announcing a new lab test panel for Apple Health app users, priced at $119.

8 sept. 2026, 23:26 UTC

Quest Diagnostics Inc shares are higher in after-market hours, reaching a peak cumulative return of 0.78%. No specific news was identified to explain this movement.

4 sept. 2026, 19:36 UTC

Quest Diagnostics shares are lower amid rising Treasury yields and expectations of tighter monetary policy from the Federal Reserve. The stock is below its 20-day moving average.

3 sept. 2026, 21:04 UTC

Quest Diagnostics Inc shares are higher in after-market trading, showing notable strength during the session. No specific news was identified to explain the movement.

2 sept. 2026, 20:03 UTC

News

Quest Diagnostics has signed a multi-year agreement with Renalytix PLC for kidney testing, contributing to shares trading higher during Wednesday's session.

1 sept. 2026, 23:36 UTC

News

Quest Diagnostics has signed a multi-year agreement with Renalytix PLC for kidneyintelX.dkd testing, contributing to a modest rise in shares during after-market hours.

31 août 2026, 23:26 UTC

Quest Diagnostics Inc is rising in after-market trading, rebounding from three days of declines. Broader market dynamics may be influencing investor sentiment.

28 août 2026, 19:46 UTC

Quest Diagnostics Inc shares are lower today, continuing a decline since Thursday. Broader market conditions and inflation concerns may be influencing the price action.

27 août 2026, 23:06 UTC

Quest Diagnostics shares are trading lower in after-market hours. The decline follows three consecutive sessions of gains amid mixed market sentiment.

26 août 2026, 19:46 UTC

Quest Diagnostics shares are lower today, reflecting broader market trends amid rising consumer prices, as indicated by the recent PCE price index data.

25 août 2026, 23:42 UTC

Correlated Moves

Quest Diagnostics Inc shares declined in after-market trading, following a similar trend seen in Labcorp Holdings Inc. The stock moved lower since Tuesday's close.

24 août 2026, 23:36 UTC

Event

Quest Diagnostics announced developments in its Alzheimer’s testing portfolio, with shares trading lower in after-market hours amid broader market volatility.

21 août 2026, 23:01 UTC

Quest Diagnostics shares declined in after-market trading, despite remaining above their 20-day moving average and near the upper end of their one-month range.

20 août 2026, 20:01 UTC

Quest Diagnostics Inc is trading higher, continuing its upward trend since Wednesday. The stock reached a session high earlier before pulling back slightly.

19 août 2026, 23:56 UTC

Quest Diagnostics Inc shares are higher in after-market hours, continuing a trend of four consecutive sessions finishing above their 20-day moving average.

17 août 2026, 19:46 UTC

Correlated Moves
News

Quest Diagnostics Inc's shares are higher, supported by Zacks Research raising Q3 EPS estimates to $2.82 from $2.79 following strong Q2 results.

12 août 2026, 19:46 UTC

Quest Diagnostics shares are higher, reflecting broader market gains from positive inflation sentiment. The stock remains above its 20-day moving average.

11 août 2026, 19:26 UTC

Quest Diagnostics shares are higher today, reflecting a general upward trend since Monday. Investors await upcoming U.S. inflation reports that may impact market sentiment.

10 août 2026, 23:36 UTC

Quest Diagnostics Inc shares are trading higher in after-market hours, showing notable upward movement despite no specific company news identified.

7 août 2026, 21:01 UTC

Quest Diagnostics Inc. shares are higher in after-market trading, reflecting strong performance above the 20-day moving average and near the one-month range's upper end.

6 août 2026, 23:01 UTC

Quest Diagnostics Inc. shares declined in after-market trading, reversing a three-session upward trend. The stock remains above its 20-day moving average.

5 août 2026, 19:36 UTC

Quest Diagnostics Inc shares are higher amid positive market sentiment and easing inflation concerns related to falling crude oil prices. The stock is near its one-month high.

4 août 2026, 22:02 UTC

Quest Diagnostics Inc shares declined in after-market trading, despite broader positive market sentiment. No specific news was identified to explain the drop.

3 août 2026, 19:46 UTC

Quest Diagnostics Inc. shares are lower today, continuing a trend of declines after four consecutive sessions of lower closes. No specific news has been identified.

31 juil. 2026, 20:04 UTC

Correlated Moves

Quest Diagnostics is lower today, reflecting broader declines in the Health Care Services sector, including a drop in Labcorp Holdings.

30 juil. 2026, 23:02 UTC

Quest Diagnostics shares are higher in after-market trading, recovering from an earlier dip. The price remains above its 20-day moving average.

29 juil. 2026, 20:08 UTC

Correlated Moves

Quest Diagnostics shares are lower amid a broader decline in the Health Care Services sub-sector, reflecting a negative trend seen since Tuesday's close.

28 juil. 2026, 23:01 UTC

Quest Diagnostics Inc shares are higher in after-market trading, maintaining upward momentum amid broader market strength and trading above their 20-day moving average.

27 juil. 2026, 17:26 UTC

News

Quest Diagnostics Inc. shares are higher today, supported by a 10% revenue increase to $3 billion for Q2 and an improved full-year outlook.

24 juil. 2026, 21:21 UTC

Quest Diagnostics Inc shares are higher in after-market hours, continuing a trend of gains over the past three sessions. No specific news was identified.

Comparaison

Variation de prix

Quest Diagnostics Inc prévision

Objectif de Prix

By TipRanks

7.86% hausse

Prévisions sur 12 Mois

Moyen 254 USD  7.86%

Haut 265 USD

Bas 245 USD

Basé sur 11 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

11 ratings

7

Achat

4

Maintien

0

Vente

Sentiment

By Acuity

12 / 339Classement par Soins de santé

Sentiment de l'Actualité

Très Fortes Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Quest Diagnostics Inc

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
help-icon Live chat